Managemenrt

& Directors

Management team

Andy Sheldon
President and Chief Executive Officer

Mr. Sheldon has been President and Chief Executive Officer of Medicago since August 2003. He has over twenty years of experience in the pharmaceutical industry. Before joining the company, Mr. Sheldon was Vice-President, Sales and Marketing, of Shire Biologics. He was responsible for international expansion with European, American and Asian private partnership agreements. He was also responsible for distribution, customer, maintenance and engineering at the Shire facility. He successfully negotiated the annual and pandemic contract with the federal and provincial governments. From 1998 to 2000, he was Senior Manager of Commercial Operations where successfully managed the approval of a bladder cancer therapeutic vaccine by the FDA. In 1997 and 1998, he was Marketing Manager for Merial Canada Inc. From 1992 to 1997, he was Director of Canadian Operations with Rhône Mérieux. From 1988 to 1992, he was National Sales Manager for Smithkline Beecham. Mr. Sheldon has a Bachelor Degree in Agricultural Sciences from Laval University, and a Bachelor of Science degree with Honours in Biological Sciences from the University of East Anglia, Norwich, England.


Louis-Philippe Vézina, Ph.D
Chief Scientific Officer

Dr. Vézina is the co-founder of Medicago. He obtained his B.Sc. degree in Agronomy from McGill University (Montreal, Canada), his M.Sc. and Ph.D. degrees in Plant biochemistry and Molecular biology from Laval University (Sainte-Foy, Canada). A researcher at Agriculture and Agri-Food Canada (Sainte-Foy, Canada) for 15 years, he gained managing experience by leading research teams, serving as Department Head, and directing graduate students and postdoctoral fellows. He has been leading the R & D section of Medicago since 1999 and is still recognized by investors as the key R & D resource.


Pierre Labbé, Chartered Accountant
Vice President and Chief Financial Officer

Pierre Labbé is a Chartered Accountant with over 20 years of financial experience. He was most recently Vice President and Chief Financial Officer of Plexmar Resources Inc. (TSX-V: PLE). Prior to Plexmar, Mr. Labbé spent three years as Vice President, Chief Financial Officer and Secretary of Medicago. He served as CFO of Sequoia Minerals Inc. and Mazarin Inc. from March 2000 to December 2003. Prior to March 2000, Mr. Labbé held management positions in accounting and finance with Agrinove, an agrifood cooperative and Coopers & Lybrand, now PricewaterhouseCoopers LLP where he was involved in many acquisitions and public financing projects. He has been Director of Advitech Inc. (TSX-V: AVI) since May 11, 2007, and Director of Mines Virginia Inc. since May 2008. He holds a degree in Business Administration and Accounting Sciences from Université Laval. He is a member of the Ordre des comptables agréés du Québec and of the Canadian Institute of Chartered Accountants.


Nathalie Landry, M.Sc., MBA
Vice-President Product Development

Ms. Landry obtained a B.Sc. in Microbiology-immunology and an MBA from Laval University (Sainte-Foy, Canada). Prior to Medicago, she worked in a biotech company holding various positions such as R & D manager, IP manager, operations, and sales.



Irene Clement,
Consultant Regulatory affairs

Ms. Irene Clement is an accomplished Senior Regulatory Professional with 26 years "hands on" experience in the Biologics industry, 21 in Regulatory Affairs. Ms. Clement has a proven track record in directing and carrying out world-wide Regulatory Affairs, in bringing products through the regulatory process dealing with US FDA, Canadian, European, and WHO regulatory authorities plus relevant authorities in other parts of the world. From Nov. 2002 to Sept 2004, she was Vice President, Regulatory Affairs. for Shire Biologics, a Division of Shire BioChem Inc. where she had Corporate global responsibility for all Regulatory matters. Prior to that, 1992 to Nov. 2002 she was Director, Regulatory Affairs, and Authorized Official at Aventis Pasteur Limited. Ms. Clement received a B.Sc. in microbiology from the University of Calgary, Alberta. She is also Medical Laboratory Technologist from Holy Cross Hospital, Calgary, Alberta.


Frederic Ors, B.Sc., M.A.
Vice-President, Business development

Mr. Ors has over ten years of experience in Licensing, Intellectual Property and business development in biotechnology. He joined Medicago in 2001 and oversees Business Development activities. He is also responsible for securing Medicago's Freedom to Operate and establishing IP strategies. Before joining Medicago, he was Licensing manager for four years at one of the largest science and medical universities in France. He has a B.Sc. degree in Biology and a Master degree in Management from Angers University (France), as well as a Diploma in Biomedical business development from Pierre et Marie Curie University (France).


Joanne Roberge
Senior Director Administration and Human Resources

Board of directors
_____________________________________

Dr. Randal Chase, Chairman of the Board and Director
Corporate Director (Former President Shire Biologics)

Mr. Damien Levesque, Director
Director Avenir Luzerne S.A.

Mr. Paul Marshall, Director
Vice-President Operations,
Amylin Pharmaceuticals

Mr. Jonathan R. Goodman, Director
President and Chief Executive Officer, Paladin Labs Inc.

Mr. Pierre Seccareccia, Director
Corporate Director

Mr. Andrew Sheldon, Director
President and Chief Executive Officer, Medicago Inc.

Dr. Louis Philippe Vézina, Director
Vice-President Research and Development, Medicago Inc.